These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12210813)

  • 1. Spontaneous reports of thrombocytopenia in association with quinine: clinical attributes and timing related to regulatory action.
    Brinker AD; Beitz J
    Am J Hematol; 2002 Aug; 70(4):313-7. PubMed ID: 12210813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA; Humphries JE; Crean S; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse effects of quinine in the treatment of leg cramps].
    Beyens MN; Guy C; Ollagnier M
    Therapie; 1999; 54(1):59-62. PubMed ID: 10216424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult quinine-induced thrombocytopenia.
    Kojouri K; Perdue JJ; Medina PJ; George JN
    J Okla State Med Assoc; 2000 Nov; 93(11):519-21. PubMed ID: 11126885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections and human tissue transplants: review of FDA MedWatch reports 2001-2004.
    Wang S; Zinderman C; Wise R; Braun M
    Cell Tissue Bank; 2007; 8(3):211-9. PubMed ID: 17278013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trocar-associated injuries and fatalities: an analysis of 1399 reports to the FDA.
    Fuller J; Ashar BS; Carey-Corrado J
    J Minim Invasive Gynecol; 2005; 12(4):302-7. PubMed ID: 16036187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008.
    Woo EJ; Wise RP; Menschik D; Shadomy SV; Iskander J; Beeler J; Varricchio F; Ball R
    Vaccine; 2011 Feb; 29(6):1319-23. PubMed ID: 21126606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of reports of depression and suicide in patients treated with isotretinoin.
    Wysowski DK; Pitts M; Beitz J
    J Am Acad Dermatol; 2001 Oct; 45(4):515-9. PubMed ID: 11568740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
    Pearson EC; Woosley RL
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Wysowski DK; Green L
    Obstet Gynecol; 1995 Apr; 85(4):538-42. PubMed ID: 7898829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated support for pharmacovigilance: a proposed system.
    Bright RA; Nelson RC
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):121-5. PubMed ID: 11998536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing nocturnal leg cramps--calf-stretching exercises and cessation of quinine treatment: a factorial randomised controlled trial.
    Coppin RJ; Wicke DM; Little PS
    Br J Gen Pract; 2005 Mar; 55(512):186-91. PubMed ID: 15808033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007.
    Gubernot DM; Lucey CT; Lee KC; Conley GB; Holness LG; Wise RP
    Clin Infect Dis; 2009 Jan; 48(1):25-30. PubMed ID: 19035776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis.
    Begier EM; Langford CA; Sneller MC; Wise RP; Ball R;
    J Rheumatol; 2004 Nov; 31(11):2181-8. PubMed ID: 15517631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diplopia and fluoroquinolones.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature.
    Raisch DW; Straight TM; Holodniy M
    Pharmacotherapy; 2009 Aug; 29(8):988-92. PubMed ID: 19637952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
    J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare data.
    Houstoun M; Reichman ME; Graham DJ; Nambiar S; Shamsuddin H; Jones SC; Cao K; Wernecke M; Lam C; Worrall CM; MaCurdy TE; Kelman JA
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):911-7. PubMed ID: 24872151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.